MYC in cancer: from undruggable target to clinical trials Nature Reviews Drug Discovery - Oncogene MYC has been considered ‘undruggable’ for many decades. This Review provides an overview of the various strategies to inhibit MYC, focusing on...

We are delighted to share that our review “MYC in cancer: from undruggable target to clinical trials” is finally out in Nature Reviews Drug Discovery. What an amazing journey this has been and still promises to be! Big thanks to co-author Jonathan Whitfield. @vhio.bsky.social
rdcu.be/eawOK